Price to Book Value (P/BV)
since 2005
Calculation
Eli Lilly & Co., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Eli Lilly and Company shareholders’ equity1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | 25.28 | = | 238.31 | ÷ | 9.43 | 9.43 | = | 8,979,200 | ÷ | 952,347,126 | |
| Feb 17, 2021 | 35.07 | = | 206.46 | ÷ | 5.89 | 5.89 | = | 5,641,600 | ÷ | 958,425,693 | |
| Feb 19, 2020 | 51.67 | = | 140.83 | ÷ | 2.73 | 2.73 | = | 2,606,900 | ÷ | 956,382,203 | |
| Feb 19, 2019 | 12.87 | = | 122.13 | ÷ | 9.49 | 9.49 | = | 9,828,700 | ÷ | 1,035,418,562 | |
| Feb 20, 2018 | 7.33 | = | 77.55 | ÷ | 10.58 | 10.58 | = | 11,592,200 | ÷ | 1,095,597,580 | |
| Feb 21, 2017 | 6.33 | = | 80.36 | ÷ | 12.70 | 12.70 | = | 14,007,700 | ÷ | 1,103,352,450 | |
| Feb 19, 2016 | 5.51 | = | 72.61 | ÷ | 13.17 | 13.17 | = | 14,571,300 | ÷ | 1,106,093,485 | |
| Feb 19, 2015 | 5.14 | = | 71.12 | ÷ | 13.84 | 13.84 | = | 15,373,200 | ÷ | 1,111,103,942 | |
| Feb 19, 2014 | 3.69 | = | 58.09 | ÷ | 15.75 | 15.75 | = | 17,631,400 | ÷ | 1,119,713,084 | |
| Feb 21, 2013 | 4.15 | = | 54.02 | ÷ | 13.02 | 13.02 | = | 14,765,200 | ÷ | 1,134,411,762 | |
| Feb 24, 2012 | 3.35 | = | 39.05 | ÷ | 11.67 | 11.67 | = | 13,541,700 | ÷ | 1,160,406,840 | |
| Feb 22, 2011 | 3.21 | = | 34.43 | ÷ | 10.73 | 10.73 | = | 12,420,300 | ÷ | 1,157,664,779 | |
| Feb 22, 2010 | 4.17 | = | 34.47 | ÷ | 8.26 | 8.26 | = | 9,523,700 | ÷ | 1,153,145,432 | |
| Feb 27, 2009 | 5.01 | = | 29.38 | ÷ | 5.86 | 5.86 | = | 6,735,300 | ÷ | 1,149,015,882 | |
| Feb 29, 2008 | 4.16 | = | 50.02 | ÷ | 12.02 | 12.02 | = | 13,664,400 | ÷ | 1,136,985,018 | |
| Feb 28, 2007 | 5.43 | = | 52.59 | ÷ | 9.68 | 9.68 | = | 10,980,700 | ÷ | 1,134,034,234 | |
| Mar 1, 2006 | 5.85 | = | 55.89 | ÷ | 9.55 | 9.55 | = | 10,791,900 | ÷ | 1,129,982,580 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Eli Lilly & Co. Annual Report.
Comparison to Competitors
Eli Lilly & Co., P/BV, long-term trends, comparison to competitors
| Eli Lilly & Co. | AbbVie Inc. | Amgen Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | 25.28 | 16.53 | 18.51 | 5.90 | 5.05 | 4.31 | 3.35 | 3.60 | 5.18 |
| Feb 17, 2021 | 35.07 | 14.18 | 14.53 | 6.72 | 7.46 | 24.16 | 2.98 | 4.81 | 5.15 |
| Feb 19, 2020 | 51.67 | — | 13.84 | 6.61 | 7.83 | 8.21 | 3.00 | 3.79 | 4.16 |
| Feb 19, 2019 | 12.87 | — | 9.41 | 6.08 | 7.79 | 4.29 | 3.80 | 5.07 | 3.75 |
| Feb 20, 2018 | 7.33 | 36.95 | 5.02 | 5.79 | 4.30 | — | 2.94 | 5.66 | 3.30 |
| Feb 21, 2017 | 6.33 | 21.24 | 4.14 | 4.72 | 4.51 | — | 3.40 | 8.58 | 2.86 |
| Feb 19, 2016 | 5.51 | 22.17 | 3.94 | 4.07 | 3.15 | — | 2.84 | 10.53 | 2.42 |
| Feb 19, 2015 | 5.14 | 56.09 | 4.59 | 4.01 | 3.42 | — | 2.95 | 16.22 | 2.51 |
| Feb 19, 2014 | 3.69 | 18.05 | 4.30 | 3.50 | 3.35 | — | 2.69 | 16.74 | 2.90 |
| Feb 21, 2013 | 4.15 | 18.06 | 3.57 | 3.29 | 2.44 | — | 2.42 | 12.91 | 1.72 |
| Feb 24, 2012 | 3.35 | — | 2.83 | 3.13 | 2.14 | — | 1.95 | 19.19 | 1.38 |
| Feb 22, 2011 | 3.21 | — | 2.04 | 2.88 | 1.85 | — | 1.75 | 6.42 | 1.41 |
| Feb 22, 2010 | 4.17 | — | 2.46 | 3.45 | 1.97 | — | 1.57 | 5.49 | 1.29 |
| Feb 27, 2009 | 5.01 | — | 2.48 | 3.56 | 2.72 | — | 1.44 | 2.94 | 1.02 |
| Feb 29, 2008 | 4.16 | — | 2.77 | 4.17 | 5.38 | — | 2.32 | 3.24 | 1.62 |
| Feb 28, 2007 | 5.43 | — | 3.96 | 4.78 | 5.45 | — | 2.49 | 5.77 | 1.38 |
| Mar 1, 2006 | 5.85 | — | 4.26 | 4.66 | 4.30 | — | 2.94 | 8.16 | 2.03 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Eli Lilly & Co., P/BV, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Eli Lilly & Co. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 23, 2022 | 25.28 | 6.23 |
| Feb 17, 2021 | 35.07 | 7.08 |
| Feb 19, 2020 | 51.67 | 7.04 |
| Feb 19, 2019 | 12.87 | 6.58 |
| Feb 20, 2018 | 7.33 | 5.11 |
| Feb 21, 2017 | 6.33 | 4.61 |
| Feb 19, 2016 | 5.51 | 3.90 |
| Feb 19, 2015 | 5.14 | 4.09 |
| Feb 19, 2014 | 3.69 | 3.62 |
| Feb 21, 2013 | 4.15 | 3.05 |
| Feb 24, 2012 | 3.35 | 2.42 |
| Feb 22, 2011 | 3.21 | 2.12 |
| Feb 22, 2010 | 4.17 | 2.22 |
| Feb 27, 2009 | 5.01 | 2.39 |
| Feb 29, 2008 | 4.16 | 3.24 |
| Feb 28, 2007 | 5.43 | 3.58 |
| Mar 1, 2006 | 5.85 | 3.88 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Eli Lilly & Co., P/BV, long-term trends, comparison to industry (health care)
| Eli Lilly & Co. | Health Care | |
|---|---|---|
| Feb 23, 2022 | 25.28 | 4.81 |
| Feb 17, 2021 | 35.07 | 4.67 |
| Feb 19, 2020 | 51.67 | 4.43 |
| Feb 19, 2019 | 12.87 | 4.44 |
| Feb 20, 2018 | 7.33 | 4.21 |
| Feb 21, 2017 | 6.33 | 3.78 |
| Feb 19, 2016 | 5.51 | 3.35 |
| Feb 19, 2015 | 5.14 | 3.69 |
| Feb 19, 2014 | 3.69 | 3.10 |
| Feb 21, 2013 | 4.15 | 2.61 |
| Feb 24, 2012 | 3.35 | 2.33 |
| Feb 22, 2011 | 3.21 | 2.07 |
| Feb 22, 2010 | 4.17 | 2.16 |
| Feb 27, 2009 | 5.01 | 2.32 |
| Feb 29, 2008 | 4.16 | 3.16 |
| Feb 28, 2007 | 5.43 | 3.65 |
| Mar 1, 2006 | 5.85 | 3.83 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).